Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Clonality and altered behavior of endothelial cells from hemangiomas
Eileen Boye, Ying Yu, Gretchen Paranya, John B. Mulliken, Bjorn R. Olsen, Joyce Bischoff
Eileen Boye, Ying Yu, Gretchen Paranya, John B. Mulliken, Bjorn R. Olsen, Joyce Bischoff
View: Text | PDF
Article

Clonality and altered behavior of endothelial cells from hemangiomas

  • Text
  • PDF
Abstract

Hemangioma, the most common tumor of infancy, is a benign vascular neoplasm of unknown etiology. We show, for the first time to our knowledge, that endothelial cells from proliferating hemangioma are clonal, and we demonstrate that these hemangioma-derived cells differ from normal endothelial cells in their rates of proliferation and migration in vitro. Furthermore, migration of hemangioma endothelial cells is stimulated by the angiogenesis inhibitor endostatin, unlike the inhibition seen with normal endothelial cells. We conclude that hemangiomas constitute clonal expansions of endothelial cells. This is consistent with the possibility that these tumors are caused by somatic mutations in one or more genes regulating endothelial cell proliferation.

Authors

Eileen Boye, Ying Yu, Gretchen Paranya, John B. Mulliken, Bjorn R. Olsen, Joyce Bischoff

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Results of HUMARA assay on DNA from ECs of control infants’ skin, hemang...
Results of HUMARA assay on DNA from ECs of control infants’ skin, hemangioma lesions, and unbound fibroblast-like cells. Amplification was performed before (–) or after (+) HhaI digestion. For each cell sample shown, the individual is heterozygous for CAG repeat size and has two different alleles before HhaI digestion, represented by two major PCR products on gel. Fainter (“stutter”) bands are products of slippage by DNA polymerase in STR region. (a) Amplification of DNA from ECs cultured at P4 to P7 from skin of two control female infants HFSEC-3 (left) and HFSEC-11 (right). In each sample, two alleles are equally amplifiable both before and after digestion. (b) Amplification of DNA from cultured hemECs from patient 1 (left) at P4 and P6 and patient 21 (right) at P5, P6, and P7. In both cases, one allele completely disappears after HhaI digestion. This selective amplification of one allele indicates that it is always methylated and not subject to digestion by HhaI and, therefore, is the only inactive allele in cell population. C is a positive control for the HUMARA assay. (c) Amplification of DNA from cultured unbound, fibroblast-like cells of hemangioma 10 at P4 (UB-P4). For comparison, DNA from cultured hemEC-10 at P5 (EC-P5) is shown at right.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts